Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2010
12/29/2010CN101926974A Chinese medicinal composition for treating dribbling of middle-aged and old people
12/29/2010CN101926862A Chinese veterinary medicament for enhancing nonspecific immunity function
12/29/2010CN101926861A Method for preparing Chinese medicinal veterinary medicament for enhancing non-specific immune function
12/29/2010CN101926789A Improved topical medicaments and methods for photodynamic treatment of disease
12/29/2010CN101926787A Application of flavone compound in protecting liver
12/29/2010CN101926776A Salinomycin sodium suspension as well as preparation method and application thereof
12/29/2010CN101503392B Aromatic aminomethane compounds, as well as preparation and medical use thereof
12/29/2010CN101422505B Foot-and-mouth disease vaccine and immunological stress resistance agent of other livestock and poultry and use thereof
12/29/2010CN101380320B The use of cholinesterase inhibitors in pharmacy
12/29/2010CN101142193B Propane-1,3-dion derivative or salt thereof
12/29/2010CN101052400B Application of pyridine compound for preparing medicine for curing injured skin
12/29/2010CA2766387A1 Novel thiophenecarboxamide derivative and pharmaceutical use thereof
12/29/2010CA2764475A1 Crystals
12/29/2010CA2752865A1 Quickly soluble oral film dosage containing steviosides as a unpleasant taste masking agent
12/28/2010USRE42015 N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections
12/28/2010USRE42014 Pharmaceutical compositions
12/28/2010US7858738 Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
12/28/2010US7858655 synergistic mixtures reduce damage to neurons after a neurodegenerative insult; time-release agents; antiischemic agents; amyotrophic lateral slerosis (ALS), Alzheimer's disease, Parkinson's disease, Hunntington's disease, multiple sclerosis
12/28/2010US7858641 melanocortin-4 receptor (MC4-R) agonists such as (3R,5S)-N-(2-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-1-oxo-1,2-dihydroisoquinolin-6-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used for the treatment of obesity or diabetes
12/28/2010US7858631 such as (3R,5S)-N-(3-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-7-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used as melanocortin-4 receptor (MC4-R) agonists, for the treatment of obesity or diabetes
12/28/2010US7858617 2-hexadecyloxy-6-methyl-4H-3,1-benzoxazin-4-one; inhibition of a lipase, esterase or phosphatase enzyme
12/28/2010US7858577 Use of the long pentraxin PTX3 for the treatment of diseases caused by an altered activation of the growth factor FGF-2
12/28/2010US7858368 Recombinant adenoviral vectors and their utility in the treatment of various types of fibrosis: hepatic, renal, pulmonary, as well as hypertrophic scars
12/28/2010US7858346 Regeneration and neogenesis of retinal visual cell-expressing Otx2 protein
12/28/2010US7858094 Controling abberant inflamatory response; obtain animal, incubate with modulator of inflammation, monitor animal for adjustment in inflammatory response
12/23/2010WO2010147449A1 Adaptogenic activity of labisia pumila extract
12/23/2010WO2010147234A1 Diarylamide-spirodiamine derivative
12/23/2010WO2010147226A1 Pyrazinooxazepine derivatives
12/23/2010WO2010147144A1 Oral liquid preparation
12/23/2010WO2010147138A1 Gene encoding fatty acid elongase, and use thereof
12/23/2010WO2010147133A1 Novel imidazopyridine compound
12/23/2010WO2010147109A1 Angiogenesis inducer comprising genetically modified gelatin and basic fibroblast growth factor
12/23/2010WO2010147094A1 Compound having spiro-bonded cyclic group and use thereof
12/23/2010WO2010147068A1 Substituted polycyclic carbamoylpyridone derivative
12/23/2010WO2010146831A1 Prenatal milk-derived composition for preventing the risk of low birthweight of newborns
12/23/2010WO2010146622A1 Nfat signal inhibitor and calcineurin inhibitor
12/23/2010WO2010145376A1 Tripeptide boronic acid or boronic ester, preparative method and use thereof
12/23/2010WO2010145207A1 Liquiritigenin derivatives, preparation methods and uses thereof
12/23/2010WO2010144959A1 Analogues of anti-fibrotic agents
12/23/2010WO2010115629A3 Amatoxin-armed therapeutic cell surface binding components designed for tumour therapy
12/23/2010WO2010020798A3 Nanoparticles
12/23/2010US20100325743 Marks as modifiers of the p53 pathway and methods of use
12/23/2010US20100324646 Biodegrdable Medical Device With Hydroxyapatite Filaments and Biodegradable Polymer Fibers
12/23/2010US20100324145 Crystalline ACAT Inhibitor
12/23/2010US20100324126 Syn3 compositions and methods
12/23/2010US20100324120 Lipid formulation
12/23/2010US20100324100 Sustained release aminopyridine compositions
12/23/2010US20100324093 Ccr9 inhibitors and methods of use thereof
12/23/2010US20100324039 Substituted Indolealkanoic Acids
12/23/2010US20100324005 Method for treatment of diseases
12/23/2010US20100323999 Therapeutic Molecules and Methods-1
12/23/2010US20100323986 Compositions and methods for modulation of vascular structure and/or function
12/23/2010US20100323981 Treatment of statin side effects
12/23/2010US20100323964 New non-selective somatostatin analogues
12/23/2010US20100323959 Methods of Use of Biomaterial and Injectable Implant Containing Biomaterial
12/23/2010US20100323958 Methods of Use of Biomaterial and Injectable Implant Containing Biomaterial
12/23/2010US20100323956 Glucose-regulating polypeptides and methods of making and using same
12/23/2010US20100323018 Branched DNA/RNA monomers and uses thereof
12/23/2010US20100323016 Modified release formulation and methods of use
12/23/2010US20100323000 Method and process for preparing cardiolipin
12/23/2010US20100322998 Skin ulcer preventive curative agent containing human recombinant hgf
12/23/2010US20100322989 Hydrophilic skin cleaning cloth
12/23/2010US20100322986 Compositions and devices
12/23/2010US20100322911 Use of microwave irradiation for delivery of macromolecules
12/23/2010US20100322899 Methods of improving central nervous system functioning
12/23/2010US20100322860 Method for determination of a potential mutation
12/23/2010US20100322854 Positron emission tomography imaging method
12/23/2010US20100322853 Nanoparticulate compositions of angiogenesis inhibitors
12/23/2010US20100322852 Nanoparticulate compositions of angiogenesis inhibitors
12/22/2010EP2264179A1 Aminosugar compound and process for production thereof
12/22/2010EP2264173A2 Use of a double-stranded ribonucleic acid for targeted inhibition of the expression of a given target gene
12/22/2010EP2264172A1 Oligomeric compounds for the modulation of HIF-1alpha expression
12/22/2010EP2264145A1 Culture system for rapid expansion of human embryonic stem cells
12/22/2010EP2264072A1 Enhancement of antibody-mediated cytotoxicity.
12/22/2010EP2264059A1 Polypeptides, cDNAs encoding the same and utilization thereof
12/22/2010EP2264050A2 Chimeric infectious DNA clones of porcine circovirus and uses thereof
12/22/2010EP2264034A1 Bicyclic pyrrole compound
12/22/2010EP2264028A1 Pyrazole compounds useful as protein kinase inhibitors
12/22/2010EP2264026A1 Alkylaminopyridine derivative
12/22/2010EP2264009A1 Pyridylaminoacetic acid compound
12/22/2010EP2263697A2 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections
12/22/2010EP2263690A2 Chimeric infectious DNA clones of porcine circovirus and uses thereof
12/22/2010EP2263689A2 Chimeric infectious DNA clones of porcine circovirus and uses thereof
12/22/2010EP2263669A1 Pharmaceutically active isoindoline derivatives
12/22/2010EP2263655A1 Pharmaceutical formulation comprising atorvastatin calcium
12/22/2010EP2263649A1 Pharmacological adjuvants based on coordination compounds of d-metals
12/22/2010EP2262754A2 Minocycline compounds and methods of use thereof
12/22/2010EP2262514A1 Agents for promoting secretion and/or suppressing decrease of adiponectin
12/22/2010EP1781601B1 Derivatives of arylsulfonamido-substituted hydroxamic acid as matrix metalloproteinases inhibitors
12/22/2010EP1453805B1 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists
12/22/2010EP1419171B1 Methods for the synthesis of a modified hemoglobin solution
12/22/2010EP1412317B1 Retinoid derivatives with antiangiogenic, antitumor and proapoptotic activities
12/22/2010EP1390037B1 Use of glucocorticoid receptor-specific antagonists for the treatment of delirium
12/22/2010EP1290182B1 Sphingosine kinase and uses thereof
12/22/2010EP1214064B1 Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores
12/22/2010EP1135496B1 Ucp5
12/22/2010CN1812973B Indazole compounds useful as protein kinase inhibitors
12/22/2010CN1662242B Pharmaceutical compositions for the treatment of diseases related to neurotrophines
12/22/2010CN1481390B Immunomodulatory peptides derived from heat shock proteins and uses thereof
12/22/2010CN101925607A Crystalline cinnamide compounds or salts thereof
1 ... 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 ... 1564